Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) [Phase 3]
Phase 3 clinical trial evaluating TAR-200 with cetrelimab or TAR-200 alone versus intravesical BCG in BCG-naïve high-risk non-muscle invasiv…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) [Phase 3]
Phase 3 trial comparing TAR-200 to intravesical chemotherapy in patients with recurrent high-risk non-muscle-invasive bladder cancer after B…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer [Phase 3]
Phase 3 trial comparing ANKTIVA plus BCG versus BCG monotherapy in high-grade non-muscle invasive bladder cancer (BCG-naïve or BCG-exposed).
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer [NA]
A completed clinical trial comparing holmium laser en-bloc resection versus conventional transurethral resection of bladder tumors for non-m…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer [Phase 1]
A Phase 1, open-label trial evaluating Belzupacap Sarotalocan (AU-011) for non-muscle-invasive bladder cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Expanded-access treatment program for the investigational gene therapy Cretostimogene Grenadanorepvec to treat non-muscle-invasive bladder c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 study is testing pembrolizumab added to intravesical gemcitabine for BCG-unresponsive non-muscle invasive bladder cancer, with the…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]
This update covers the completion of a Phase I/II study evaluating intravesical VG161, an oncolytic virus, for BCG-unresponsive non-muscle-i…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating intravesical Bacillus Calmette-Guérin in combination with ALT-803 (N-803) for non-muscle invasive bladder cance…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer [Phase 3]
This ClinicalTrials.gov entry updates the Phase 3 S1602 study evaluating different strains of Bacillus Calmette-Guérin (BCG) with or without…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) [Phase 3]
Phase 3 clinical trial evaluating Verity-BCG for safety and efficacy in BCG-naïve patients with intermediate- and high-risk non-muscle-invas…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer [Phase 3]
Phase 3 study evaluating TAR-210 versus intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC [Phase 4]
A Phase 4 trial comparing neoadjuvant short-term intensive chemoresection to standard adjuvant intravesical instillations in non-muscle inva…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
A Mayo Clinic-sponsored clinical trial comparing urine-based molecular testing to cystoscopy for surveillance in non-muscle invasive bladder…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer [Phase 3]
Pfizer's Phase 3 trial of sasanlimab in non-muscle invasive bladder cancer has posted results and the study is currently listed as active bu…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor [NA]
A completed clinical trial comparing en bloc versus conventional transurethral resection of bladder tumors evaluating pathological outcomes …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer [NA]
The document notes the completion of a clinical trial evaluating en bloc transurethral resection for non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 dose-escalation study of UGN-301 in patients with recurrent non-muscle invasive bladder cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations [Phase 1, Phase 2]
Early-phase clinical update on TYRA-300 showing safety signals and preliminary anti-tumor activity in locally advanced or metastatic urothel…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC [EARLY_Phase 1]
Early-phase study evaluating safety, tolerability, radiation dosimetry, and imaging properties of 89Zr-labeled girentuximab in patients with…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) [Phase 4]
This Phase 4 trial is assessing whether VI-RADS imaging followed by photodynamic TURBT (PDD-TURBT) can avoid secondary resections in non-mus…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection [Phase 2, Phase 3]
A completed Phase 2/3 trial from Ain Shams University investigated whether the osmolarity of postoperative irrigation fluids influences the …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and anti-tumor activity of ATO-101 in patients with non-muscle-invasive bladder cancer. T…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab, alone or with other investigational agents, in participants with high-risk non-muscle inv…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients
This clinical trial evaluated the concordance of genomic alterations between urine and tissue in high-risk non-muscle-invasive bladder cance…